Catalent, Inc.·4

Dec 12, 7:28 PM ET

Gennadios Aristippos 4

4 · Catalent, Inc. · Filed Dec 12, 2023

Insider Transaction Report

Form 4
Period: 2023-12-08
Gennadios Aristippos
Group Pres. Pharma & Consumer
Transactions
  • Award

    Common Stock

    [F1][F2]
    2023-12-08+1,50596,863 total
  • Tax Payment

    Common Stock

    [F2]
    2023-12-08$37.18/sh367$13,64596,496 total
Footnotes (2)
  • [F1]Received upon the achievement of the fiscal 2021-23 performance-based vesting criteria set forth in certain incentive compensation held by the reporting person under the Issuer's long-term incentive plan.
  • [F2]Includes restricted stock units.
Signature
/s/ Amy Fallone, attorney-in-fact|2023-12-12

Documents

1 file
  • 4
    wk-form4_1702427322.xmlPrimary

    FORM 4